Selected research
Market Structure
Global Riluzole Tablet Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Riluzole Tablet market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Riluzole Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Riluzole Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Riluzole Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Riluzole Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Riluzole Tablet include Apotex, Covis Pharma, Glemark Generics, Italfarmaco, Lunan Pharma, Mylan Pharma, Sanofi and Sun Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Riluzole Tablet market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Riluzole Tablet and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Riluzole Tablet sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Riluzole Tablet market size, projected growth trends, production technologies, key applications, and end-use industries.
Riluzole Tablet Segment by Company
Apotex
Covis Pharma
Glemark Generics
Italfarmaco
Lunan Pharma
Mylan Pharma
Sanofi
Sun Pharma
Riluzole Tablet Segment by Type
With Film-coated
Without Film-coated
Riluzole Tablet Segment by Application
Hospital
Pharmacy
Riluzole Tablet Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Riluzole Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Riluzole Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Riluzole Tablet.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Riluzole Tablet market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Riluzole Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Riluzole Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Riluzole Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- With Film-coated
- Without Film-coated
Applications
- Hospital
- Pharmacy
Companies covered
- Apotex
- Covis Pharma
- Glemark Generics
- Italfarmaco
- Lunan Pharma
- Mylan Pharma
- Sanofi
- Sun Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Riluzole Tablet Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Riluzole Tablet Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Riluzole Tablet Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Riluzole Tablet Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Riluzole Tablet Market Dynamics
- 2.1 Riluzole Tablet Industry Trends
- 2.2 Riluzole Tablet Industry Drivers
- 2.3 Riluzole Tablet Industry Opportunities and Challenges
- 2.4 Riluzole Tablet Industry Restraints
3 Riluzole Tablet Market by Manufacturers
- 3.1 Global Riluzole Tablet Revenue by Manufacturers (2021-2026)
- 3.2 Global Riluzole Tablet Sales by Manufacturers (2021-2026)
- 3.3 Global Riluzole Tablet Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Riluzole Tablet Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Riluzole Tablet Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Riluzole Tablet Manufacturers, Product Type & Application
- 3.7 Global Riluzole Tablet Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Riluzole Tablet Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Riluzole Tablet Players Market Share by Revenue in 2025
- 3.8.3 2025 Riluzole Tablet Tier 1, Tier 2, and Tier 3
4 Riluzole Tablet Market by Type
- 4.1 Riluzole Tablet Type Introduction
- 4.1.1 With Film-coated
- 4.1.2 Without Film-coated
- 4.2 Global Riluzole Tablet Sales by Type
- 4.2.1 Global Riluzole Tablet Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Riluzole Tablet Sales by Type (2021-2032)
- 4.2.3 Global Riluzole Tablet Sales Market Share by Type (2021-2032)
- 4.3 Global Riluzole Tablet Revenue by Type
- 4.3.1 Global Riluzole Tablet Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Riluzole Tablet Revenue by Type (2021-2032)
- 4.3.3 Global Riluzole Tablet Revenue Market Share by Type (2021-2032)
5 Riluzole Tablet Market by Application
- 5.1 Riluzole Tablet Application Introduction
- 5.1.1 Hospital
- 5.1.2 Pharmacy
- 5.2 Global Riluzole Tablet Sales by Application
- 5.2.1 Global Riluzole Tablet Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Riluzole Tablet Sales by Application (2021-2032)
- 5.2.3 Global Riluzole Tablet Sales Market Share by Application (2021-2032)
- 5.3 Global Riluzole Tablet Revenue by Application
- 5.3.1 Global Riluzole Tablet Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Riluzole Tablet Revenue by Application (2021-2032)
- 5.3.3 Global Riluzole Tablet Revenue Market Share by Application (2021-2032)
6 Global Riluzole Tablet Sales by Region
- 6.1 Global Riluzole Tablet Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Riluzole Tablet Sales by Region (2021-2032)
- 6.2.1 Global Riluzole Tablet Sales by Region (2021-2026)
- 6.2.2 Global Riluzole Tablet Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Riluzole Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Riluzole Tablet Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Riluzole Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Riluzole Tablet Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Riluzole Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Riluzole Tablet Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Riluzole Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Riluzole Tablet Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Riluzole Tablet Revenue by Region
- 7.1 Global Riluzole Tablet Revenue by Region
- 7.1.1 Global Riluzole Tablet Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Riluzole Tablet Revenue by Region (2021-2026)
- 7.1.3 Global Riluzole Tablet Revenue by Region (2027-2032)
- 7.1.4 Global Riluzole Tablet Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Riluzole Tablet Revenue (2021-2032)
- 7.2.2 North America Riluzole Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Riluzole Tablet Revenue (2021-2032)
- 7.3.2 Europe Riluzole Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Riluzole Tablet Revenue (2021-2032)
- 7.4.2 Asia-Pacific Riluzole Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Riluzole Tablet Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Riluzole Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Apotex
- 8.1.1 Apotex Company Information
- 8.1.2 Apotex Business Overview
- 8.1.3 Apotex Riluzole Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Apotex Riluzole Tablet Product Portfolio
- 8.1.5 Apotex Recent Developments
- 8.2 Covis Pharma
- 8.2.1 Covis Pharma Company Information
- 8.2.2 Covis Pharma Business Overview
- 8.2.3 Covis Pharma Riluzole Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Covis Pharma Riluzole Tablet Product Portfolio
- 8.2.5 Covis Pharma Recent Developments
- 8.3 Glemark Generics
- 8.3.1 Glemark Generics Company Information
- 8.3.2 Glemark Generics Business Overview
- 8.3.3 Glemark Generics Riluzole Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Glemark Generics Riluzole Tablet Product Portfolio
- 8.3.5 Glemark Generics Recent Developments
- 8.4 Italfarmaco
- 8.4.1 Italfarmaco Company Information
- 8.4.2 Italfarmaco Business Overview
- 8.4.3 Italfarmaco Riluzole Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Italfarmaco Riluzole Tablet Product Portfolio
- 8.4.5 Italfarmaco Recent Developments
- 8.5 Lunan Pharma
- 8.5.1 Lunan Pharma Company Information
- 8.5.2 Lunan Pharma Business Overview
- 8.5.3 Lunan Pharma Riluzole Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Lunan Pharma Riluzole Tablet Product Portfolio
- 8.5.5 Lunan Pharma Recent Developments
- 8.6 Mylan Pharma
- 8.6.1 Mylan Pharma Company Information
- 8.6.2 Mylan Pharma Business Overview
- 8.6.3 Mylan Pharma Riluzole Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Mylan Pharma Riluzole Tablet Product Portfolio
- 8.6.5 Mylan Pharma Recent Developments
- 8.7 Sanofi
- 8.7.1 Sanofi Company Information
- 8.7.2 Sanofi Business Overview
- 8.7.3 Sanofi Riluzole Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Sanofi Riluzole Tablet Product Portfolio
- 8.7.5 Sanofi Recent Developments
- 8.8 Sun Pharma
- 8.8.1 Sun Pharma Company Information
- 8.8.2 Sun Pharma Business Overview
- 8.8.3 Sun Pharma Riluzole Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Sun Pharma Riluzole Tablet Product Portfolio
- 8.8.5 Sun Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Riluzole Tablet Value Chain Analysis
- 9.1.1 Riluzole Tablet Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Riluzole Tablet Production Mode & Process
- 9.2 Riluzole Tablet Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Riluzole Tablet Distributors
- 9.2.3 Riluzole Tablet Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst